StockMarketWire.com - Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 9500p (from 9000p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk